This is a working overview of nitric oxide, written for readers who want more than a one-paragraph summary but less than a textbook.
Reviewed 2026-05-09. Anything still debated is marked as such rather than presented as settled.
Evidence in humans is limited. Small clinical studies have examined the peptide in contexts such as ulcerative colitis and wound healing, but participant numbers are small and independent replication is scarce. It is not approved as a medicine by major regulatory agencies and is distributed mainly as a research material or compounded preparation. Long-term human safety data are not established, and questions about absorption through non-injected routes remain open rather than resolved. Claims about its effects are best read against these gaps.
BPC-157 is a synthetic peptide of fifteen amino acids, written in single-letter code as GEPPPGKPADDAGLV. The sequence corresponds to a partial fragment of a protein isolated from human gastric juice, described in early reports as body protection compound. The number 157 refers to a fragment designation in that work rather than to molecular mass. Initial descriptions appeared in the early 1990s, when the fragment was reported to protect gastrointestinal tissue in animal models. Commercial material is produced by solid-phase peptide synthesis rather than extracted from biological sources.
Laboratory research on this peptide has examined a wide and heterogeneous set of endpoints, including gastric ulcer models, tendon and ligament injury, wound closure, and intestinal inflammation. Most published findings come from rodent studies, and reported effect sizes are often large relative to controls. Because the compound has been tested across many unrelated injury models, the literature is frequently described as unusually broad for a single peptide. A substantial share of this work originates from a small number of research groups, which matters when assessing how widely results have been reproduced.
Identity and purity are established with complementary methods rather than one test. Reverse-phase high-performance liquid chromatography separates the main peak from deletion sequences and oxidized variants, and its area percentage is the usual purity figure. Mass spectrometry confirms the expected molecular mass and can flag truncations or modifications that chromatography alone might miss. Amino acid analysis and peptide mapping add sequence-level confirmation, while residual counter-ion and water content are measured separately.
A freeze-dried sample is generally the most stable form and is commonly held at minus twenty degrees Celsius or lower for long-term keeping, with brief transfers at room temperature. The solid is hygroscopic, so vials are warmed to ambient temperature before opening to prevent condensation from degrading the contents. Light exposure and repeated temperature cycling are both avoided in routine handling. Storage over a desiccant is a common laboratory practice that limits moisture uptake during repeated access.
Once dissolved, the material is considerably less stable than the dry solid. Aqueous solutions are usually kept cold and used within a short window, and neutral or mildly acidic buffers are preferred over strongly alkaline conditions. Freeze-thaw cycles promote aggregation and loss of material to container surfaces, so dividing a batch into single-use aliquots is standard. Adsorption to plastic and glass can lower the measured concentration, meaning solution strength may need rechecking before an experiment.
| Property | Value | Notes |
|---|---|---|
| Class | Synthetic peptide | Linear, fifteen residues |
| Sequence | GEPPPGKPADDAGLV | Single-letter amino acid code |
| Approximate mass | 1419 Da | Value reported for the free peptide |
| Reported origin | Fragment of a gastric juice protein | Used as the design template |
| Common synonyms | Body protection compound 157; PL 14736 | Naming varies across papers and suppliers |
Material of this kind is sold for laboratory research, and labels typically state that it is not intended for human or veterinary use. In many countries it is not an approved medicine, and sports antidoping rules place it among prohibited non-approved substances. Buyers commonly review a certificate of analysis, an independent test report, and the declared storage conditions. Batch-to-batch variation in purity and in counterion content is possible, and how much that variation affects experimental outcomes remains an open question.
Lyophilized peptide is normally kept at minus twenty degrees Celsius or colder, away from light and moisture. Powder held under those conditions is widely treated as stable for long periods, although published stability studies for this exact sequence are sparse and often come from suppliers rather than independent laboratories. Once dissolved, solutions are generally handled cold and used within a short window, because peptide bonds can hydrolyze over time. Repeated freeze-thaw cycles are usually avoided to limit losses, and exact shelf-life figures depend on the buffer and the concentration involved.
Purity is ordinarily reported as a percentage from reverse-phase high-performance liquid chromatography, where the area of the main peak is compared with the total peak area. Identity is confirmed by mass spectrometry, since the measured mass can be checked against the value calculated from the sequence. Some certificates also include amino acid analysis or sequence confirmation by tandem mass spectrometry. A single purity number does not describe the profile of related impurities, so the underlying chromatogram and spectrum usually carry more information than the headline figure.
Identity and purity are usually assessed with reversed-phase high-performance liquid chromatography, often paired with mass spectrometry using electrospray or MALDI ionisation. Amino acid analysis and peptide mapping by enzymatic digestion provide additional sequence-level confirmation. Purity is commonly reported as an area percentage from a chromatographic trace, and water content can be measured by Karl Fischer titration. Reported masses may differ by tens of daltons between sources because preparations can contain acetate or trifluoroacetate counterions, and such differences are not by themselves evidence of a different peptide.
BPC-157 is normally distributed as a lyophilised powder that ranges from white to off-white in appearance. The peptide dissolves readily in water, normal saline, and common aqueous buffers, and it is poorly soluble in nonpolar solvents such as hexane or vegetable oils. Lyophilised vials take up moisture if left open, which changes the mass of powder in the container and complicates any later weighing. Because the material is handled in small quantities, static and adhesion to glass or plastic can also cause noticeable losses during transfer.
The main chemical liabilities of this sequence are peptide-bond hydrolysis and possible aspartate-related reactions, since the peptide contains aspartic acid residues but no cysteine, methionine, or tryptophan. Absence of those three residues removes the most common oxidation and disulfide pathways from consideration. Studies of related peptides indicate that aspartate isomerisation and aspartimide formation occur most readily at Asp-Gly and Asp-Ala positions, and open questions remain about how quickly those reactions proceed under ordinary laboratory conditions. Storage guidance typically emphasises cool, dry, dark conditions to slow hydrolysis.
Dry powder is generally stored at low temperature, with minus twenty degrees Celsius or colder advised for extended retention. Reconstituted solutions are less stable than the solid form and are normally kept cold and shielded from repeated freeze-thaw cycles. Light exposure is avoided because some peptides degrade under ultraviolet radiation. The exact rate of degradation depends on concentration, pH, and the presence of salts, so a single shelf life does not apply to every preparation. Reported stability figures should be read as indicative of typical handling rather than as universal constants.
Confirmation of identity and purity relies on standard peptide analysis techniques. Reverse-phase high-performance liquid chromatography separates the peptide from related impurities and serves as the most common purity assay. Mass spectrometry, often coupled to that chromatography step, provides an accurate molecular mass that can be matched against the expected value. Amino acid analysis or sequencing can be added for further confirmation. Because short peptides can be produced by different synthetic routes, laboratories usually report both a chromatographic purity percentage and a mass confirmation rather than a single figure.
BPC-157 is commonly supplied as a lyophilized powder, a freeze-dried solid that is reconstituted before use in laboratory work. As a short peptide, it dissolves readily in water and in aqueous buffer solutions, and stock solutions are typically prepared in water or a mild buffer. The chain contains several proline and acidic residues, which influence how it behaves in solution. Because the solid can take up moisture, weighing and handling are usually performed under low-humidity conditions. Its solubility class is described as freely soluble in water rather than requiring an organic solvent.
Published studies on BPC-157 are dominated by animal models. Commonly used endpoints include healing of surgically induced lesions in the stomach, tendon-to-bone attachment after transection, and recovery from experimentally induced vascular or intestinal damage. Many of these reports come from a small number of research groups, and the peptide is often described as acting across a wide range of tissue types. That breadth is itself a point of discussion, since one molecule influencing many unrelated systems is unusual.
Human data are far more limited than animal data. A small number of clinical reports exist, generally with few participants and without the randomization or blinding expected in later-phase trials. No large, independently replicated human trial has appeared in the indexed peer-reviewed literature. Statements about effects in people therefore rest on extrapolation from animal work rather than on direct evidence, and the strength of that extrapolation remains an open question rather than a settled matter.
== Background == Sudan had multi-member Sovereignty Councils holding the role of head of state of Sudan several times during the twentieth century. Following more than half a year of sustained civil disobedience and a shift of the presidency from Omar al-Bashir to the Transitional Military Council (TMC) in April 2019 by a coup d'état, the TMC and the Forces of Freedom and Change alliance (FFC) made a July 2019 Political Agreement and completed it by the August 2019 Draft Constitutional Declaration. Articles 9.(a) and 10.(a) of the August 2019 Draft Constitutional Declaration both transfer the role of head of state to the Sovereignty Council.
=== Radio wave absorption === Stacked graphene layers on a quartz substrate increased the absorption of millimeter (radio) waves by 90 per cent over 125–165 GHz bandwidth, extensible to microwave and low-terahertz frequencies, while remaining transparent to visible light. For example, graphene could be used as a coating for buildings or windows to block radio waves. Absorption is a result of mutually coupled Fabry–Perot resonators represented by each graphene-quartz substrate. A repeated transfer-and-etch process was used to control surface resistivity.
In the face of this radical liberation of the musical material, Adorno came to criticize those who, like Stravinsky, withdrew from this freedom by taking recourse to forms of the past as well as those who turned twelve-tone composition into a technique that dictated the rules of composition. Adorno saw the culture industry as an arena in which critical tendencies or potentialities were eliminated. He argued that the culture industry, which produced and circulated cultural commodities through the mass media, manipulated the population. Popular culture was identified as a reason why people become passive; the easy pleasures available through consumption of popular culture made people docile and content, no matter how terrible their economic circumstances. "Capitalist production so confines them, body and soul, that they fall helpless victims to what is offered them." The differences among cultural goods make them appear different, but they are in fact just variations on the same theme. He wrote that "the same thing is offered to everybody by the standardized production of consumption goods," but the truth is concealed under "the manipulation of taste and the official culture's pretense of individualism." By doing so, the culture industry appeals to every single consumer in a unique and personalized way, all while maintaining minimal costs and effort on their behalf.
== Determination of activity == Activity of glutathione peroxidase is measured spectrophotometrically using several methods. A direct assay by linking the peroxidase reaction with glutathione reductase with measurement of the conversion of NADPH to NADP is widely used. The other approach is measuring residual GSH in the reaction with Ellman's reagent. Based on this, several procedures for measuring glutathione peroxidase activity were developed using various hydroperoxides as substrates for reduction, e.g. cumene hydroperoxide, tert-butyl hydroperoxide and hydrogen peroxide. The other methods include the use of CUPRAC reagent with spectrophotometric detection of the reaction product or o-phtalaldehyde as a fluorescent reagent.
Traditionally, many drugs and other chemicals with biological activity have been discovered by studying chemicals that organisms create to affect the activity of other organisms for survival. Despite the rise of combinatorial chemistry as an integral part of lead discovery process, natural products still play a major role as starting material for drug discovery. A 2007 report found that of the 974 small molecule new chemical entities developed between 1981 and 2006, 63% were natural derived or semisynthetic derivatives of natural products. For certain therapy areas, such as antimicrobials, antineoplastics, antihypertensive and anti-inflammatory drugs, the numbers were higher. Natural products may be useful as a source of novel chemical structures for modern techniques of development of antibacterial therapies.
Sources: en.wikipedia.org
=== Global teaching and research === Arizona partnership with Universidad de Sonora was renewed in August 2017, focusing on a partnership in geology and physics. Arizona has been part of both theoretical and experimental research in particle and nuclear physics in the framework of the CERN program since 1987. The collaboration was initiated by the theoretician Peter A. Carruthers, head of the physics department, and Johann Rafelski who initiated the quark-gluon-plasma program at CERN. Arizona officially joined the CERN-LHC ATLAS Collaboration in 1994. Arizona has a strategic program to attract foreign scholars, in particular from China. Following a 2024 report by the United States House Select Committee on Strategic Competition between the United States and the Chinese Communist Party and the United States House Committee on Education and Workforce, Arizona closed its four micro-campuses in China.
The cost of data loggers has been declining over the years as technology improves and costs are reduced. Simple single-channel data loggers can cost as little as $25, while more complicated loggers may cost hundreds or thousands of dollars.
purple passion fruit (fruits of Passiflora edulis Sims) yellow passion fruit (Passiflora edulis f. flavicarpa Deg.) sweet granadilla (Passiflora ligularis) giant granadilla (Passiflora quadrangularis L.) banana passion fruit (fruits of Passiflora tarminiana)
Reference Model of Open Distributed Processing (RM-ODP) is a reference model in computer science, which provides a co-ordinating framework for the standardization of open distributed processing (ODP). It supports distribution, interworking, platform and technology independence, and portability, together with an enterprise architecture framework for the specification of ODP systems. RM-ODP, also named ITU-T Rec. X.901-X.904 and ISO/IEC 10746, is a joint effort by the International Organization for Standardization (ISO), the International Electrotechnical Commission (IEC) and the Telecommunication Standardization Sector (ITU-T).
In combined mass spectra obtained by summing a large number of individual ion detection events, each peak is a histogram obtained by adding up counts in each individual bin. Because the recording of the individual ion arrival with TDC yields only a single time point, the TDC eliminates the fraction of peak width determined by a limited response time of both the MCP detector and preamplifier. This propagates into better mass resolution. Modern ultra-fast 10 GSample/sec analog-to-digital converters digitize the pulsed ion current from the MCP detector at discrete time intervals (100 picoseconds). Modern 8-bit or 10-bit 10 GHz ADC has much higher dynamic range than the TDC, which allows its usage in MALDI-TOF instruments with its high peak currents. To record fast analog signals from MCP detectors one is required to carefully match the impedance of the detector anode with the input circuitry of the ADC (preamplifier) to minimize the "ringing" effect. Mass resolution in mass spectra recorded with ultra-fast ADC can be improved by using small-pore (2-5 micron) MCP detectors with shorter response times.
Sources: en.wikipedia.org
The above discussion is based on the ideal vapour-compression refrigeration cycle, and does not take into account real-world effects like frictional pressure drop in the system, slight thermodynamic irreversibility during the compression of the refrigerant vapor, or non-ideal gas behavior, if any. Vapor compression refrigerators can be arranged in two stages in cascade refrigeration systems, with the second stage cooling the condenser of the first stage. This can be used for achieving very low temperatures. More information about the design and performance of vapor-compression refrigeration systems is available in the classic Perry's Chemical Engineers' Handbook.
The Korean War, which began in 1950, was a shock to the US military and highlighted the deficiencies in psychological warfare. In spite of this, United Nations Partisan Forces Korea operated on islands and behind enemy lines. These forces were also known as the 8086th Army Unit, and later as the Far East Command Liaison Detachment, Korea, FECLD-K 8240th Army Unit. These troops directed North Korean partisans in raids, harassment of supply lines, and the rescue of downed pilots. Experience gained in the Korean War by these units influenced the development of U.S. Army Special Forces doctrine. Special Forces were formed in 1952, initially under the U.S. Army Psychological Warfare Division headed by then Brigadier General Robert A. McClure, due to the identified need to have psychological warfare capabilities. McClure specialized in psychological warfare but had little experience in unconventional warfare, though he believed the two were inextricably linked. Special Operations Command was formed by the U.S. Army Psychological Warfare Center which was activated in May 1952. The initial 10th Special Forces Group was formed in June 1952 and was commanded by Colonel Aaron Bank who is known as the father of Special Forces. The first Executive Officer was LTC William C. Martin, Jr. The 10th SFG's formation coincided with the establishment of the Psychological Warfare School, which is now known as the John F. Kennedy Special Warfare Center and School.
1908: George W. McCoy's discovery that rodents were a reservoir of bubonic plague. 1911: George W. McCoy, Charles W. Chapin, William B. Wherry, and B. H. Lamb described the previously unknown tularemia. 1924: Roscoe R. Spencer and Ralph R. Parker developed a vaccine against Rocky Mountain spotted fever. 1930: Sanford M. Rosenthal developed a treatment for mercury poisoning used widely before the development of dimercaptoethanol. 1943: Wilton R. Earle pioneered the cell culture process and published a paper describing the production of malignancy in vitro, Katherine K. Sanford developed the first clone from an isolated cancer cell, and Virginia J. Evans devised a medium that supported growth of cells in vitro. 1940s–1950s: Bernard Horecker and colleagues described the pentose phosphate pathway. 1950s: Julius Axelrod discovered a new class of enzymes, cytochrome P450 monooxygenases, a fundamental of drug metabolism. 1950: Earl Stadtman discovered phosphotransacetylose, elucidating the role of acetyl CoA in fatty acid metabolism. 1960s: Discovered the first human slow virus disease, kuru, which is a degenerative, fatal infection of the central nervous system. This discovery of a new mechanism for infectious diseases revolutionized thinking in microbiology and neurology. 1960s: Defined the mechanisms that regulate noradrenaline, one of the most important neurotransmitters in the brain. 1960s: Developed the first licensed rubella vaccine and the first test for rubella antibodies for large scale testing.
Modern biochemical research has been greatly aided by the development of new techniques such as chromatography, NMR spectroscopy, electron microscopy and molecular dynamics simulations. These techniques have allowed the discovery and detailed analysis of the many molecules and metabolic pathways in cells.
Fu's Subcutaneous Needle (FSN), invented by Dr. Zhonghua Fu in 1996, is a method for the treatment of myofascial pain and trigger points related to Traditional Chinese Medicine (TCM) and invented by Dr. D. Simons and Dr. Janet G. Travell. FSN does not follow the rules and principles of TCM and the chosen insertion points do not coincide with traditional acupuncture points. The similarities are limited to the distal insertion of the needle to the affected area, the needle itself being a non-injection needle, and the fact that both needles are manipulated and act on soft connective tissue. FSN abstains from the muscle and deep fascia layers and is confined to only the subcutaneous layer where collagen fibers are most abundant. As the subcutaneous layer is poorly innervated, pain is less than other needling therapies. FSN is also currently being used to treat non-musculoskeletal conditions; however more research is to be carried out to conclude its effectiveness.
Sources: en.wikipedia.org
It is a synthetic fifteen-amino-acid peptide whose sequence matches part of a protein found in human gastric juice. It is made by chemical synthesis, not purified from tissue. The name derives from an early fragment label, not from a molecular weight.
The sequence corresponds to a segment of a naturally occurring gastric protein, so related sequence material exists in the body. The peptide itself as sold and studied is a laboratory-synthesized product. Whether an identical free peptide circulates naturally is not established.
No major regulatory agency has approved it as a medicine for any indication. It appears in research supply channels and, in some jurisdictions, in compounded preparations. Clinical use therefore sits outside standard approved-product pathways, and regulatory status varies by country.
Low temperature slows the chemical reactions, such as oxidation and hydrolysis, that break down a peptide chain. Water and oxygen are the main drivers of degradation, so a cold and dry environment extends usable life. Actual shelf life depends on the batch, the salt form, and the container.